Lv11
45 积分 2021-10-18 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
7小时前
已完结
Can multispecific biologics break the efficacy ceiling?
28天前
已完结
Multispecific T-cell engagers attract cancer drug developers
28天前
已完结
Antibody–Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond
1个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
1个月前
已完结
A proteomics approach for the identification and cloning of monoclonal antibodies from serum
2个月前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
2个月前
已完结
A fully integrated microfluidic device for cell electrofusion and quick acquisition of hybridoma cells with high production of monoclonal antibody
2个月前
已完结
Bifunctional Compounds as Molecular Degraders for Integrin-Facilitated Targeted Protein Degradation
3个月前
已完结
Roadmap for Optimizing and Broadening Antibody-Based PROTACs for Degradation of Cell Surface Proteins
3个月前
已完结
皖公网安备34019202002308
